Science & Enterprise subscription

Follow us on Twitter

  • The Federal Reserve, the U.S. central bank, released statistics showing in April 2020, manufacturing output dropped… https://t.co/q390P26pNf
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Largest Ever U.S. Manufacturing Decline https://t.co/WkZSpIfnoj #Science #Business
    about 2 days ago
  • Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a… https://t.co/7K5to9yzvX
    about 3 days ago
  • New post on Science and Enterprise: Covid-19 Therapies Designed with Virtual Reality, A.I. https://t.co/4DK0JUeOiF #Science #Business
    about 3 days ago
  • A spin-off company from a university engineering lab received funds to build a device that efficiently splits water… https://t.co/nm0ArWQ3E3
    about 3 days ago

Please share Science & Enterprise

In Case You Missed It …

(tigerlily713, Pixabay)

29 July 2018. Among our favorite stories on Science & Enterprise are when interesting science becomes a business opportunity. Last Wednesday, we reported on Convelo Therapeutics, a spin-off enterprise from Case Western Reserve University in Cleveland, commercializing research by its two geneticist founders that stimulate stem cells to replenish damaged myelin around nerve cells in the brain. Myelin is the waxy substance protecting nerve cells that gets destroyed by multiple sclerosis. The company emerged from stealth mode when the founders published papers in two Nature journals on Wednesday.

Here are other stories we covered last week:

*     *     *

Please share Science & Enterprise ...

Comments are closed.